{"id":"https://openalex.org/W73501708","doi":null,"title":"Clinical trials in CNS--SMi's eighth annual conference.","display_name":"Clinical trials in CNS--SMi's eighth annual conference.","publication_year":2010,"publication_date":"2010-02-01","ids":{"openalex":"https://openalex.org/W73501708","mag":"73501708","pmid":"https://pubmed.ncbi.nlm.nih.gov/20127552"},"language":"en","primary_location":{"id":"pmid:20127552","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20127552","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055182829","display_name":"Rebecca Kirk","orcid":"https://orcid.org/0000-0003-3541-0168","observed_orcids":["https://orcid.org/0000-0003-3541-0168"]},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Rebecca Kirk","raw_affiliation_strings":["Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. rebecca.kirk@thomsonreuters.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. rebecca.kirk@thomsonreuters.com","institution_ids":["https://openalex.org/I4210090249"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055182829"],"corresponding_institution_ids":["https://openalex.org/I4210090249"],"apc_list":null,"apc_paid":null,"fwci":0.3346,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.50079211,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"13","issue":"2","first_page":"66","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9121000170707703,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9121000170707703,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0722000002861023,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6470000147819519},{"id":"https://openalex.org/keywords/central-nervous-system-diseases","display_name":"central nervous system disorders","score":0.984000027179718},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/alzheimer-s-disease-neuroimaging-initiative","display_name":"Alzheimer's Disease Neuroimaging Initiative","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pipamperone","display_name":"pipamperone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.6759999990463257},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/spinal-muscular-atrophy","display_name":"spinal muscular atrophy","score":1.0},{"id":"https://openalex.org/keywords/olesoxime","display_name":"olesoxime","score":0.9670000076293945},{"id":"https://openalex.org/keywords/investigational-drugs","display_name":"investigational drugs","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7335814237594604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6568986177444458},{"id":"https://openalex.org/C58693492","wikidata":"https://www.wikidata.org/wiki/Q551875","display_name":"Neuroimaging","level":2,"score":0.5543022155761719},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.5452523827552795},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5444296002388},{"id":"https://openalex.org/C2778558090","wikidata":"https://www.wikidata.org/wiki/Q580290","display_name":"Spinal muscular atrophy","level":3,"score":0.4429369866847992},{"id":"https://openalex.org/C2778373026","wikidata":"https://www.wikidata.org/wiki/Q4738819","display_name":"Alzheimer's Disease Neuroimaging Initiative","level":4,"score":0.4289368689060211},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.35957518219947815},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3360171616077423},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.31748414039611816},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.30408528447151184},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27519118785858154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24045172333717346}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:20127552","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20127552","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2107218881","https://openalex.org/W2314200914","https://openalex.org/W2054187799","https://openalex.org/W2896874468","https://openalex.org/W2514623569","https://openalex.org/W2323960354","https://openalex.org/W2441448964","https://openalex.org/W2087380762","https://openalex.org/W2118037675","https://openalex.org/W3095153932"],"abstract_inverted_index":{"The":[0],"SMi's":[1],"Eighth":[2],"Annual":[3],"Conference":[4],"on":[5,31],"Clinical":[6],"Trials":[7],"in":[8,11,19,79],"CNS,":[9],"held":[10],"London,":[12],"included":[13],"topics":[14],"covering":[15],"new":[16],"therapeutic":[17],"developments":[18],"the":[20,36,43,57,61],"field":[21],"of":[22,38,42,59,65,72],"CNS":[23],"disorders.":[24],"This":[25],"conference":[26],"report":[27],"highlights":[28],"selected":[29],"presentations":[30],"emerging":[32],"clinical":[33,77],"targets":[34],"for":[35],"treatment":[37],"Alzheimer's":[39,44,53],"disease,":[40],"achievements":[41],"Disease":[45],"Neuroimaging":[46],"Initiative,":[47],"computational":[48],"assessment":[49],"methods":[50],"applicable":[51],"to":[52,56],"disease":[54],"and":[55,74,76,83,95],"monitoring":[58],"suicidality,":[60],"accelerated":[62],"antidepressive":[63],"effect":[64],"PNB-01":[66],"(PharmaNeuroBoost":[67],"NV;":[68],"comprising":[69],"a":[70],"combination":[71],"pipamperone":[73],"citalopram),":[75],"trials":[78],"amyotrophic":[80],"lateral":[81],"sclerosis":[82],"spinal":[84],"muscular":[85],"atrophy.":[86],"Investigational":[87],"drugs":[88],"discussed":[89],"also":[90],"include":[91],"begacestat":[92],"(Pfizer":[93],"Inc)":[94],"olesoxime":[96],"(Trophos":[97],"SA).":[98]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}